Gilead Sciences to acquire US-based Ouro Medicines for up to $2 billion
Gilead Sciences, Inc., will acquire Ouro Medicines, a privately held biotechnology company focused on developing T cell engager therapies for autoimmune diseases, for
Gilead Sciences, Inc., will acquire Ouro Medicines, a privately held biotechnology company focused on developing T cell engager therapies for autoimmune diseases, for
Novartis AG has agreed to buy an investigational oral medicine of Pikavation Therapeutics, a subsidiary of privately-held Synnovation Therapeutics, to treat breast cancer, for
Switzerland’s F. Hoffmann-La Roche AG upgraded its artificial intelligence infrastructure by deploying Nvidia’s technology to accelerate development of diagnostic solutions and therapeutics.
About 4.9 million children died before their fifth birthday in 2024, including 2.3 million newborns, according to a UN report.
HQ Staff Writer March 17, 2026 : Public health officials in the United Kingdom are racing to contain a fatal outbreak of meningitis B in
High antibiotic use may have a long-term effect on a person’s gut microbiome, and certain antibiotics can cause changes in the community of
HQ Team March 16, 2026: Academy Award-winning actress Lupita Nyong’o has ignited a vital global conversation about uterine fibroids after sharing a powerful
Six small ribonucleic acid (RNA) molecules in the blood may be able to predict short-term survival with an 86% accuracy, a study finds.
A 13,000-year-old ice cave, located in Romania’s northwestern Apuseni mountains of Transylvania, is housing bacteria that are resistant to about 10 modern antibiotics
Ravens remember where wolves are most likely to make kills and will return to those kill sites from far away — flying up